Higher UV Index Predicts Very Slightly Lower Inflammatory Pain for Population

Higher UV Index Predicts Very Slightly Lower Inflammatory Pain for Population

Contents

Variables

A
UV Index 595
A
Inflammatory Pain 1047

Categories

A
Environment 564
A
Symptoms 13336

Tags

High Confidence
Very Weak Effect Size
Negative Relationship
Population Study
cause image gauge image effect image
Participants reported a 11.1% average decrease in Inflammatory Pain following above average UV Index.

Abstract

Inflammatory Pain was generally 5.4% lower than average after 5.58 index of UV Index per 24 hours.

Aggregated data from 1 study participants suggests with a HIGH degree of confidence (p=0.0745, 95% CI -0.179 to 0.029) that UV Index has a very weakly negative predictive relationship (R=-0.0749) with Inflammatory Pain.

The highest quartile of Inflammatory Pain measurements were observed following an average 5.32 index UV Index.

The lowest quartile of Inflammatory Pain measurements were observed following an average 5.58 index of UV Index.

After an onset delay of 0 seconds, Inflammatory Pain is typically 1% lower than average over the 24 hours following around 5.58 index of UV Index UV Index.

Keywords: UV Index, Inflammatory Pain, N-of-1 trials, real-world evidence, causal inference, observational study

Preliminary: Based on 1 participants. Results may change as more data is collected.

Results

Primary Findings

Analysis of 861 paired observations from 1 participants revealed a modest reduction in Inflammatory Pain following above-average UV Index exposure.

-5.4%
Change from Baseline
Modest effect on Inflammatory Pain
0.01
Predictor Impact Score
Insufficient evidence for causal relationship

Supporting Statistics

High
Confidence
-0.075
Correlation (r)
p = 1.000
Significance
z = 0.13
Effect Magnitude
φ = 1.00
Temporality

What This Means

When participants had above-average UV Index:

  • Inflammatory Pain decreased by 5.4% on average
  • Temporal analysis supports UV Index as the predictor (not the outcome)

Interpreting the Predictor Impact Score

The Predictor Impact Score (PIS) integrates multiple Bradford Hill causal criteria into a single metric. Use this guide to interpret the score:

PIS Range Interpretation Recommended Action
≥ 0.5 Strong evidence High priority for RCT validation
0.3 - 0.5 Moderate evidence Consider for experimental investigation
0.1 - 0.3 Weak evidence Monitor for additional data
< 0.1 Insufficient evidence Low priority; may be noise

Note: PIS is a prioritization heuristic, not proof of causation. High scores indicate relationships worth investigating, not confirmed causal effects. With only 1 participants, these scores are preliminary and will become more reliable as additional data is collected.

Optimal Daily Values

No clear dose-response relationship detected. The UV Index values associated with high and low Inflammatory Pain are too similar to provide meaningful dosing guidance. This may indicate a threshold effect (any amount works equally well), no effect, or insufficient data variance. With more participants, a clearer pattern may emerge.

Population Correlation

UV Index Distribution

Inflammatory Pain Distribution

Relationship Analysis

Statistical Summary

Relationship Statistics

Property Value
Cause Variable Name UV Index
Effect Variable Name Inflammatory Pain
Sinn Predictive Coefficient 0.0071276775116247
Confidence Level HIGH
Confidence Interval 0.10381067929243
Forward Pearson Predictive Coefficient -0.0749
Critical T Value 1.646
Average UV Index Over Previous 24 hours Before ABOVE Average Inflammatory Pain 5.32 index
Average UV Index Over Previous 24 hours Before BELOW Average Inflammatory Pain 5.58 index
Duration of Action 24 hours
Effect Size very weakly negative
Number of Paired Measurements 861
Optimal Pearson Product 0.006205099132163
P Value 0.07453466323796
Statistical Significance 1
Strength of Relationship 0.10381067929243
Study Type population
Analysis Performed At 2026-01-04
Number of Participants 1

UV Index Info

Property Value
Variable Name UV Index
Aggregation Method MEAN
Analysis Performed At 2022-08-10
Duration of Action 24 hours
Kurtosis 1.822010060732
Mean 5.9878842271663 index
Median 5.9006088992974 index
Minimum Allowed Value 0 index
Number of Aggregate Predictors 32
Number of Aggregate Outcomes 563
Number of Measurements 2808
Number of Measurements (including those generated by tagged, joined, or child variables) 2808
Public true
Onset Delay 0 seconds
Standard Deviation 2.4107553795229
Unit Index
User Variables 1004
UPC 0
Variable Category Environment
Variable ID 5974181
Variance 6.7284308269145

Inflammatory Pain Info

Property Value
Variable Name Inflammatory Pain
Aggregation Method MEAN
Analysis Performed At 2022-10-14
Duration of Action 24 hours
Kurtosis 3.4846383984834
Maximum Allowed Value 5 out of 5
Mean 3.0539571428571 out of 5
Median 3.0714285714286 out of 5
Minimum Allowed Value 1 out of 5
Number of Aggregate Predictors 880
Number of Aggregate Outcomes 167
Number of Measurements 1013
Number of Measurements (including those generated by tagged, joined, or child variables) 2081
Public true
Onset Delay 0 seconds
Standard Deviation 0.39795851007474
Unit 1 to 5 Rating
User Variables 14
UPC 753970618156
Variable Category Symptoms
Variable ID 1340
Variance 0.28757898061717

Introduction

Background

UV Index (Environment) and Inflammatory Pain (Symptoms) are both important factors in understanding human health and well-being. This study investigates the relationship between these two variables using real-world observational data.

Traditional randomized controlled trials (RCTs), while the gold standard for causal inference, are often impractical, expensive, or unethical for studying many health relationships. Aggregated N-of-1 observational studies offer a complementary approach that leverages within-subject comparisons across large populations to identify meaningful patterns.

Research Question

Does UV Index affect Inflammatory Pain?

Additionally, we seek to determine:

  1. What is the direction and magnitude of any effect?
  2. How confident can we be in this relationship based on the available data?
  3. What are the optimal levels of UV Index for maximizing Inflammatory Pain?

Study Objective

The objective of this study is to determine the nature of the relationship (if any) between UV Index and Inflammatory Pain. Additionally, we attempt to determine the UV Index values most likely to produce optimal Inflammatory Pain values.

Study Overview

This is a population-level observational study using aggregated N-of-1 methodology. By aggregating individual N-of-1 experiments, we can identify population-level patterns while accounting for the substantial individual variation that exists in most health relationships. Effect sizes are reported as percent change from baseline, enabling intuitive interpretation and comparison across different measures.

Full Methodology: Framework for Real-World Evidence-Based Pharmacovigilance: Aggregated N-of-1 Trials for Quantifying Treatment Effects

Discussion

Interpretation of Findings

Participants experienced a 5.4% reduction in Inflammatory Pain following above-average UV Index exposure. The Predictor Impact Score (PIS) of 0.01 indicates insufficient evidence for a causal relationship.

Statistical Significance

Using a two-tailed t-test with alpha = 0.05, it was determined that the change in Inflammatory Pain is statistically significant at a 95% confidence interval. The p-value of 1.0000 indicates there is less than a 100.00% probability that this result occurred by chance.

After treatment, a 11.1% decrease (-0.116 out of 5) from the mean baseline 2.14 out of 5 was observed. The relative standard deviation at baseline was 43.2%. The observed change was 0.13 times the standard deviation.

A common rule of thumb considers a change greater than twice the baseline standard deviation on two separate pre-post experiments may be considered significant. This occurrence would have only a 5% likelihood of resulting from random fluctuation (a p-value < 0.05).

T-Test Details
Observed t-value: 1.832
Critical t-value: 1.646

Since t = 1.83 > 1.65, we reject the null hypothesis.

Biological Plausibility

A plausible bio-chemical mechanism between predictor and outcome is critical for interpreting observational findings. This is where human judgment excels beyond statistical analysis.

Community feedback on the biological plausibility of this relationship is still being collected. Consider the known mechanisms by which UV Index might influence Inflammatory Pain.

Bradford Hill Criteria Assessment

The Bradford Hill criteria provide a framework for assessing causality in observational studies. Our methodology operationalizes six of the nine criteria through the Predictor Impact Score (PIS):

Criterion How Addressed Metric
Strength Effect size magnitude Percent change from baseline (Δ%), z-score
Consistency Cross-participant replication Number of users (N), number of pairs (n)
Temporality Predictor precedes outcome Temporality factor (φ), onset delay (δ > 0)
Biological Gradient Dose-response relationship Gradient coefficient (φgradient)
Plausibility Biological mechanism assessment Community votes on mechanism plausibility
Specificity Category appropriateness Interest factor (finterest)

Predictor Impact Score (PIS)

The PIS integrates multiple Bradford Hill criteria into a composite metric quantifying how reliably a predictor affects an outcome. Higher scores indicate stronger evidence:

Population-Level PIS:

$$\text{PIS}_{\text{agg}} = |r_{\text{forward}}| \cdot w \cdot \phi_{\text{users}} \cdot \phi_{\text{pairs}} \cdot \phi_{\text{change}} \cdot \phi_{\text{gradient}}$$

Where φ-factors are saturation functions approaching 1 as evidence accumulates:

  • φusers = 1 - e-N/10 (user saturation)
  • φpairs = 1 - e-n/nsig (pair saturation)
  • φchange = 1 - e-Δspread/Δsig (effect spread saturation)
  • w = weighted average of plausibility votes

Temporality Assessment

We assess evidence for correct causal direction using the temporality factor:

$$\phi_{\text{temporal}} = \frac{|r_{\text{forward}}|}{|r_{\text{forward}}| + |r_{\text{reverse}}|}$$

Values approaching 1 indicate the predictor precedes the outcome (supporting causation); values near 0.5 suggest ambiguous directionality; values near 0 suggest reverse causation or confounding by indication.

Limitations

As with any observational study, correlation does not prove causation. Key limitations include:

  • Unmeasured confounders: Variables not tracked may influence results
  • Self-selection bias: Health trackers may differ from the general population
  • Measurement error: Self-reported data may contain recall bias
  • Confounding by indication: Sicker individuals may use more treatments

However, within-subject comparison and temporal precedence analysis partially mitigate these limitations. If the relationship is merely coincidental, as participants independently modify their UV Index values, the observed strength will decline over time. Spurious correlations naturally dissipate as more data is collected.

Future Directions

Future research should examine:

  • Subgroup analyses to identify individual differences in response
  • Potential confounders and mediators of the observed relationship
  • Optimal dosing and timing for UV Index
  • Confirmation through prospective or randomized designs
  • Biological mechanisms underlying the observed effects

Conclusion

📊 Preliminary Findings: With 1 participants, these results are based on limited data. Effect sizes and confidence will improve as more participants contribute data. Consider these findings directional rather than definitive.

Above-average UV Index was associated with a 5.4% reduction in Inflammatory Pain—a modest effect. The Predictor Impact Score of 0.01 indicates this relationship is requiring additional data before conclusions.

Bottom Line: Based on a PIS of 0.01 and a 5.4% effect size, this relationship currently lacks sufficient evidence. Continue monitoring as more data becomes available. Note: These conclusions may strengthen or change direction as more data is collected.

These findings contribute to our understanding of how UV Index may influence Inflammatory Pain in real-world conditions. While preliminary, these results may inform future research directions. As more participants contribute data, the reliability and precision of these findings will improve substantially.

Help End Unnecessary Suffering

Current clinical trials are 82x more expensive than necessary and take 17 years to bring treatments to market. Pragmatic trials integrated into standard healthcare could reduce costs from $41,000 to $500 per participant and compress timelines to just 2 years. Learn how redirecting just 1% of global military spending could accelerate cures for the 2 billion people suffering from treatable diseases.

Make Suffering Optional

Methods

Study Design

This study is based on data donated by 1 participants. Thus, the study design is equivalent to the aggregation of 1 separate n=1 observational natural experiments.

This within-subject design is powerful because it controls for all stable individual characteristics (genetics, baseline health status, socioeconomic factors) that might otherwise confound the relationship between variables.

Data Analysis

Temporal Assumptions

The analysis incorporates temporal assumptions about the relationship between variables:

  • Onset Delay: It was assumed that 0 seconds would pass before a change in UV Index would produce an observable change in Inflammatory Pain.
  • Duration of Action: It was assumed that UV Index could produce an observable change in Inflammatory Pain for as much as 24 hours after the stimulus event.

Statistical Methods

For each participant, we calculated the Pearson correlation coefficient between UV Index values and subsequent Inflammatory Pain values. Individual correlations were then aggregated using Fisher's z-transformation to produce a population-level estimate:

Individual Correlation:

$$r_i = \frac{\sum(x_{ij} - \bar{x}_i)(y_{ij} - \bar{y}_i)}{\sqrt{\sum(x_{ij} - \bar{x}_i)^2 \sum(y_{ij} - \bar{y}_i)^2}}$$

Fisher's Z-Transformation:

$$z_i = \frac{1}{2} \ln\left(\frac{1 + r_i}{1 - r_i}\right)$$

Aggregated Correlation:

$$\bar{r} = \tanh(\bar{z}) \quad \text{where} \quad \bar{z} = \frac{1}{N}\sum_{i=1}^{N} z_i$$

Effect Size Calculation

Effect sizes are reported as percent change from baseline. For each participant, we compare the outcome following above-average predictor values to the overall baseline outcome:

$$\Delta\%_{\text{baseline}} = \frac{\bar{O}_{\text{follow-up}} - \bar{O}_{\text{baseline}}}{\bar{O}_{\text{baseline}}} \times 100$$

Effect Magnitude (Z-Score)

To assess effect magnitude relative to natural variability, we calculate the z-score:

$$z = \frac{|\Delta\%_{\text{baseline}}|}{\text{RSD}_{\text{baseline}}}$$

where RSDbaseline is the relative standard deviation of outcome during baseline period

A z-score > 2 indicates statistical significance (p < 0.05), meaning the observed change exceeds typical baseline fluctuation and is unlikely due to random variation.

Statistical Significance

Correlation significance is assessed using a two-tailed t-test:

$$t = \frac{r\sqrt{n-2}}{\sqrt{1-r^2}}$$

We reject the null hypothesis (ρ = 0) at α = 0.05 when |t| exceeds the critical value, providing statistical evidence that the observed relationship is not due to chance.

Data Sources

UV Index data was primarily collected using Weather. Automatically import temperature, humidity, and ultraviolet light exposure.

Inflammatory Pain data was primarily collected using QuantiModo. QuantiModo allows you to easily track mood, symptoms, or any outcome you want to optimize in a fraction of a second. You can also import your data from over 30 other apps and devices. QuantiModo then analyzes your data to identify which hidden factors are most likely to be influencing your mood or symptoms.

Data Quality

Data quality measures were applied to ensure reliable results:

  • Minimum Data Requirement: Only participants with sufficient paired observations were included in the analysis.
  • Outlier Handling: Extreme values were winsorized to reduce the influence of measurement errors.
  • Missing Data: Days with missing values were handled using appropriate filling strategies based on the variable type.
  • Test User Exclusion: Test accounts and invalid users were excluded from all analyses.

Principal Investigator

Program & Methods

Mike P. Sinn
Sinn, M. P.

Designed and implemented data collection, aggregation, causal inference pipeline, and automated study generation framework. Developed the Predictor Impact Score methodology operationalizing Bradford Hill criteria for ranking causal relationships in observational data. When he tells people this at parties, they usually say they have to go check on their car.

Individual study outputs are automated, reproducible, and open to external audit. (Which I would seriously recommend.)

Contact

Cite This Study

APA Format
Sinn, M. P. (2026). Causal Analysis: Does UV Index Affect Inflammatory Pain?. The Journal of Citizen Science. https://studies.crowdsourcingcures.org/study/cause-5974181-effect-1340-population-study
BibTeX 
@misc{sinn_cause_5974181_effect_1340_population_study_2026,
  author = {Sinn, Mike P.},
  title = {Causal Analysis: Does UV Index Affect Inflammatory Pain?},
  year = {2026},
  publisher = {The Journal of Citizen Science},
  url = {https://studies.crowdsourcingcures.org/study/cause-5974181-effect-1340-population-study},
  note = {Accessed: January 10, 2026}
}
Chicago/Turabian
Sinn, Mike P. "Causal Analysis: Does UV Index Affect Inflammatory Pain?." The Journal of Citizen Science. Accessed January 10, 2026. https://studies.crowdsourcingcures.org/study/cause-5974181-effect-1340-population-study.
Harvard
Sinn, M.P., 2026. Causal Analysis: Does UV Index Affect Inflammatory Pain?. [Aggregated N-of-1 Study] The Journal of Citizen Science. Available at: https://studies.crowdsourcingcures.org/study/cause-5974181-effect-1340-population-study [Accessed January 10, 2026].

Study Type: Aggregated N-of-1 Observational Mega-Study
Evidence Level: Level II (Real-World Evidence)
Methodology: Bradford Hill Criteria with Predictor Impact Score (PIS)

References

This framework was originally developed in 2013 based on the Bradford Hill criteria. Subsequent literature has independently validated similar approaches to causal inference from observational data:

  1. Hill, A.B. (1965). The environment and disease: association or causation? Proceedings of the Royal Society of Medicine, 58(5), 295-300. [Bradford Hill criteria]
  2. Lillie, E.O., et al. (2011). The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Personalized Medicine, 8(2), 161-173. [N-of-1 methodology]
  3. Pearl, J. (2009). Causality: Models, Reasoning, and Inference . Cambridge University Press. [Causal inference]
  4. Hernán, M.A., & Robins, J.M. (2020). Causal Inference: What If . Chapman & Hall/CRC. [Free textbook]
  5. FDA (2018). Framework for FDA's Real-World Evidence Program . U.S. Food and Drug Administration. [Regulatory context]
  6. Duan, N., et al. (2013). Single-patient (n-of-1) trials: a pragmatic clinical decision methodology . Journal of Clinical Epidemiology, 66(8), S21-S28.
  7. Platt, R., et al. (2018). The FDA Sentinel Initiative—an evolving national resource . New England Journal of Medicine, 379(22), 2091-2093.

This information is for research and educational purposes only, not medical advice. Consult a healthcare provider before making health decisions. Terms of Service

LinkedIn Reddit